
Vineet Laboratories Limited (VINEETLAB.BO)
VINEETLAB.BO Stock Price Chart
Explore Vineet Laboratories Limited interactive price chart. Choose custom timeframes to analyze VINEETLAB.BO price movements and trends.
VINEETLAB.BO Company Profile
Discover essential business fundamentals and corporate details for Vineet Laboratories Limited (VINEETLAB.BO) to support your stock research and investment decisions.
Sector
Basic Materials
Industry
Chemicals
IPO Date
15 Jun 2021
Employees
79.00
Website
https://vineetlabs.co.inCEO
Gaddam Venkata Ramana
Description
Vineet Laboratories Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients and fine chemicals in India. It offers intermediates of lopinavir, ritonavir, efavirenz, nadolol, glimepiride, celecoxib, olanine, and other API intermediates; and fine chemicals and reagents, such as isopropyl-beta-d-thiogalactopyranoside, 4-nitrophenyl phosphate disodium salt, 5-bromo-4-chloro-3-indolyl-beta-d-galactopyranoside, 5-acetyl thiophene-2-carboxilic acid, 4-chlorobutyryl chloride, n-butyl magnesium chloride, 3-furaldehyde, 3-bromofuran, n-butylnitrite, ethyldiazo acetate, phenylboronic acid, 6-aminouracil, and 1-methyl-imidazole-2-carboxaldehyde. The company was incorporated in 2016 and is based in Hyderabad, India.
VINEETLAB.BO Financial Timeline
Browse a chronological timeline of Vineet Laboratories Limited corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 31 Dec 2023
EPS came in at -₹2.24 , while revenue for the quarter reached ₹326.47M .
Dividend declared on 19 Sept 2022
A dividend of ₹1.00 per share was announced, adjusted to ₹1.00. The dividend was paid on 28 Oct 2022.
VINEETLAB.BO Stock Performance
Access detailed VINEETLAB.BO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.